This trial is testing whether a dietary supplement called citicoline will improve sleep and cognition in people with Alzheimer's disease. Citicoline has been shown to be well tolerated in previous studies.
2 Primary · 3 Secondary · Reporting Duration: Baseline and 3 months
2 Treatment Groups
1 of 2
1 of 2
20 Total Participants · 2 Treatment Groups
Primary Treatment: Citicoline supplement · Has Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants has the research team recruited for this project?
"Affirmative. Clinicaltrials.gov indicates that this research trial, which was initially posted on July 27th 2022, is still actively seeking participants. The current goal is to enroll 20 individuals from two different medical facilities." - Anonymous Online Contributor
Are there any available spaces for participants in this research endeavor?
"Per the details available on clinicaltrials.gov, this research is currently enrolling participants and has been since its original posting date of July 27th 2022 - no updates have taken place in the interim." - Anonymous Online Contributor